Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.

The oncologist - 8 May 2023

Stenzinger Albrecht, Cuffel Brian, Paracha Noman, Vail Eric, Garcia-Foncillas Jesus, Goodman Clifford, Lassen Ulrik, Vassal Gilles, Sullivan Sean D

Abstract excerpt

BACKGROUND: Adoption of high-throughput, gene panel-based, next-generation sequencing (NGS) into routine cancer care is widely supported, but hampered by concerns about cost. To inform policies regarding genomic testing strategies, we propose a simple metric, cost per correctly identified patient (CCIP), that compares sequential single-gene testing (SGT) vs. multiplex NGS in different tumor types. MATERIALS AND...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to High-Throughput Nucleotide Sequencing

Share to In Situ Hybridization, Fluorescence

Share to Lung Neoplasms

Share to Medical Oncology

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 36961477
DOI: 10.1093/oncolo/oyad005
PMCID: PMC10166172

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.PMID 36961477Read ↗

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French studySemantic proximity Read ↗

Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer.Semantic proximity Read ↗

Diagnostic and economic value of biomarker testing for targetable mutations in non-small-cell lung cancer: a literature review.Semantic proximity Read ↗

Genomic testing in oncology to improve clinical outcomes while optimizing utilization: the evolution of diagnostic testing.Semantic proximity Read ↗

Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non–Small Cell Lung CancerSemantic proximity Read ↗

Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer.Semantic proximity Read ↗

Micro-costing Diagnostics in Oncology: From Single-Gene Testing to Whole Genome SequencingSemantic proximity Read ↗

Value-based genomicsSemantic proximity Read ↗

Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel.Semantic proximity Read ↗

Personalized Medicine: Genomics Trials in Oncology.Semantic proximity Read ↗

Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancerSemantic proximity Read ↗

Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.